ST Pharm
ST Pharm
  • 01Who we are
  • 02Our record
  • 03Newsroom
  • 04Contact
    • En
    • Ko
ST Pharm
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
Public
IR Materials
  • PR (Public Relations)
    • News room
      • All
      • Media Focus
      • ST PHARM News
  • IR (Investor Relations)
    • Stock Information
    • IR Library
      • Disclosure Information
      • IR Materials
      • Notice

IR Library

  • Disclosure Information
  • IR Materials
  • Notice
[IR Materials] mRNA Platform Technology Mar 14, 2023
[Analyst Report] 4Q review: Oligo-driven strength Feb 17, 2023
[Earnings Summary] ST PHARM 4Q. 2022 Earnings Summary Feb 17, 2023
[Presentation] ST PHARM IR Preentation (Feb. 2023) Feb 6, 2023
[Analyst Report] Fundamentals intact despite noise Jan 16, 2023
[Analyst Report] Value of mRNA platform growing Dec 16, 2022
[Analyst Report] 3Q disappoints as clients adjust production volume Nov 1, 2022
[Analyst Report] Forward path clear Oct 20, 2022
[Analyst Report] OP in line on growing oligonucleotide sales Aug 11, 2022
[Presentation] ST PHARM IR Presentation (August 2022) Aug 5, 2022
[R&D Materials] STP0404 POSTER Presentation in CROI 2020 May 26, 2022
[Presentation] ST PHARM mRNA platform May 20, 2022
[Presentation] ST PHARM IR Presentation (April 2022) May 9, 2022
[Analyst Report] Focus on where it is headed, not where it is now Apr 29, 2022
1of2
HOMEPublicIR (Investor Relations)IR LibraryIR Materials
  • Science & Technology
    • Business Overview
    • CDMO
      • Small Molecule
      • Oligonucleotide
      • mRNA
    • CRO
      • AnaPath Research & Service
    • R&D
      • Virtual R&D
      • Global R&D
  • About
    • ST PHARM
    • Key Members
    • History
    • Global Approval
    • ST Pharm Family
  • Public
    • PR (Public Relations)
      • News room
        • All
        • Media Focus
        • ST PHARM News
    • IR (Investor Relations)
      • Stock Information
      • IR Library
        • Disclosure Information
        • IR Materials
        • Notice
  • Careers
  • ESG
    • Overview
    • Environmental
    • Social
    • Governance
  • Sitemap
  • Contact
  • Linkedin
© 2023 ST Pharm. All rights reserved.
  • Sitemap
  • Contact